Testing

Genes indicating risk for Alzheimer's disease identified using new testing methods |  Health

Genes indicating risk for Alzheimer’s disease identified using new testing methods | Health

A new UCLA-led study has used a combination of novel testing methods to identify several novel risk genes for Alzheimer’s disease and a related rare brain disorder called progressive supranuclear palsy (PSP) through mass variant screening genetics in a single experiment. The study, which has been published in the journal ‘Science’, also includes a new …

Genes indicating risk for Alzheimer’s disease identified using new testing methods | Health Read More »

Biomarker testing informs individualized diagnosis and treatment of low-to-intermediate risk AML

Biomarker testing informs individualized diagnosis and treatment of low-to-intermediate risk AML

Alexander E. Perl, MD, MS. According to Alexander E. Perl, MD, MS, the acute myeloid leukemia (AML) treatment landscape includes emerging therapies and diagnostic strategies that simultaneously address previously unmet needs and raise further questions regarding the classification of diseases. In 2022, the European LeukemiaNet (ELN) updated its AML recommendations based on a growing understanding …

Biomarker testing informs individualized diagnosis and treatment of low-to-intermediate risk AML Read More »

Study finds 'likely biological and genetic overlap' between carpal tunnel syndrome and migraine

Genetic testing for prostate cancer increases after introduction of point-of-care program

News — December 14, 2022 – Some prostate cancer patients have genetic mutations that may affect their treatment. A comprehensive on-site genetic testing program, developed by urologists, could help fill the gap for this underutilized resource, a study reports. Urology practice®an official journal of the American Urological Association (AUA). The journal is published in the …

Genetic testing for prostate cancer increases after introduction of point-of-care program Read More »

Robert C. Green: By sharing their genetic risks, Hemsworth and Jolie raise awareness about testing

Robert C. Green: By sharing their genetic risks, Hemsworth and Jolie raise awareness about testing

When actor Chris Hemsworth, aka Thor, God of Thunder, agreed to host a National Geographic series about extending human lifespans, he didn’t expect to discover his own genetic risk. But that’s what happened when Hemsworth revealed on an episode of “Limitless” that he carries a common change in the APOE gene associated with an increased …

Robert C. Green: By sharing their genetic risks, Hemsworth and Jolie raise awareness about testing Read More »

By Sharing Their Genetic Risks, Hemsworth and Jolie Raise Awareness About Testing, by Robert C. Green

By Sharing Their Genetic Risks, Hemsworth and Jolie Raise Awareness About Testing, by Robert C. Green

Robert C. Green Chicago Tribune When actor Chris Hemsworth, aka Thor, God of Thunder, agreed to host a National Geographic series about extending human lifespans, he didn’t expect to discover his own genetic risk. But that’s what happened when Hemsworth revealed on an episode of “Limitless” that he carries a common change in the APOE …

By Sharing Their Genetic Risks, Hemsworth and Jolie Raise Awareness About Testing, by Robert C. Green Read More »

Rare Disease Genetic Testing Market Report 2022: Rising Patients Getting Tested Presents Opportunities

Rare Disease Genetic Testing Market Report 2022: Rising Patients Getting Tested Presents Opportunities

company logo Rare Disease Genetic Testing Market Rare Disease Genetic Testing Market Dublin, Nov. 30, 2022 (GLOBE NEWSWIRE) — The “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty; by technology; by type of disease; by end use; by region; Segment forecast, 2022-2030″ report has been added to from ResearchAndMarkets.com offer. …

Rare Disease Genetic Testing Market Report 2022: Rising Patients Getting Tested Presents Opportunities Read More »